{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:28:29Z","timestamp":1771928909131,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1C1C1009196"],"award-info":[{"award-number":["2020R1C1C1009196"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01810-2","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:43:41Z","timestamp":1771926221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human serum hypoxanthine as a biomarker to predict recurrent major depressive disorder: a cross-sectional metabolomic study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4070-1614","authenticated-orcid":false,"given":"Yeeun","family":"Yun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-2087","authenticated-orcid":false,"given":"Seungyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-8984","authenticated-orcid":false,"given":"Sora","family":"Mun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-2483","authenticated-orcid":false,"given":"Hee-Gyoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1987-4109","authenticated-orcid":false,"given":"Jiyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"1810_CR1","doi-asserted-by":"publisher","unstructured":"Ait Tayeb AEK, Poinsignon V, Chappell K, Bouligand J, Becquemont L, Verstuyft C (2023) Major depressive disorder and oxidative stress: a review of peripheral and genetic biomarkers according to clinical characteristics and disease stages. Antioxidants 12:942.\u00a0https:\/\/doi.org\/10.3390\/antiox12040942","DOI":"10.3390\/antiox12040942"},{"key":"1810_CR2","doi-asserted-by":"publisher","unstructured":"Akarachantachote N, Chadcham S, Saithanu K (2014) Cutoff threshold of variable importance in projection for variable selection. Int J Pure Appl Math 94:307\u2013322.\u00a0https:\/\/doi.org\/10.1016\/j.aca.2009.02.002","DOI":"10.1016\/j.aca.2009.02.002"},{"key":"1810_CR3","doi-asserted-by":"publisher","unstructured":"Ali-Sisto T, Tolmunen T, Toffol E, Viinam\u00e4ki H, M\u00e4ntyselk\u00e4 P, Valkonen-Korhonen M, Honkalampi K, Ruusunen A, Velagapudi V, Lehto SM (2016) Purine metabolism is dysregulated in patients with major depressive disorder. Psychoneuroendocrinology 70:25\u201332.\u00a0https:\/\/doi.org\/10.1016\/j.psyneuen.2016.04.017","DOI":"10.1016\/j.psyneuen.2016.04.017"},{"key":"1810_CR4","unstructured":"Association AP (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American psychiatric association"},{"key":"1810_CR5","doi-asserted-by":"publisher","unstructured":"Bartoli F, Burnstock G, Crocamo C, Carr\u00e0 G (2020) Purinergic signaling and related biomarkers in depression. Brain Sci 10:160.\u00a0https:\/\/doi.org\/10.3390\/brainsci10030160","DOI":"10.3390\/brainsci10030160"},{"key":"1810_CR6","doi-asserted-by":"publisher","unstructured":"Causs\u00e9 E, Pradelles A, Dirat B, Negre-Salvayre A, Salvayre R, Couderc F (2007) Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum\/plasma by CE. Electrophoresis 28:381\u2013387.\u00a0https:\/\/doi.org\/10.1002\/elps.200600205","DOI":"10.1002\/elps.200600205"},{"key":"1810_CR9","doi-asserted-by":"publisher","unstructured":"Chen J, Li T, Qin X, Du G, Zhou Y (2022) Integration of non-targeted metabolomics and targeted quantitative analysis to elucidate the synergistic antidepressant effect of bupleurum Chinense DC-Paeonia lactiflora pall herb pair by regulating purine metabolism. Front Pharmacol 13:900459.\u00a0https:\/\/doi.org\/10.3389\/fphar.2022.900459","DOI":"10.3389\/fphar.2022.900459"},{"key":"1810_CR7","doi-asserted-by":"crossref","unstructured":"Chen C-Y, Wang Y-F, Lei L, Zhang Y (2024)\u00a0Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder. Life Sci 351:122815","DOI":"10.1016\/j.lfs.2024.122815"},{"key":"1810_CR8","doi-asserted-by":"publisher","unstructured":"Chen C, Xiao Q, Wen Z, Gong F, Zhan H, Liu J, Li H, Jiao Y (2025a) Gut microbiome-derived indole-3-carboxaldehyde regulates stress vulnerability in chronic restraint stress by activating aryl hydrocarbon receptors. Pharmacol Res 213:107654.\u00a0https:\/\/doi.org\/10.1016\/j.phrs.2025.107654","DOI":"10.1016\/j.phrs.2025.107654"},{"key":"1810_CR10","doi-asserted-by":"publisher","unstructured":"Chen X, Zhang K, Li Y, Wang C, Lou H, Yu S (2025b) Stress induces behavioral disorders by promoting microglial phagocytosis via decreasing neuronal Dkk3. Mol Psychiatry 30:5731\u20135748. https:\/\/doi.org\/10.1038\/s41380-025-03314-4","DOI":"10.1038\/s41380-025-03314-4"},{"key":"1810_CR11","doi-asserted-by":"publisher","unstructured":"Du H, Zhang H, Zhao Y, Liu M, Chen A, Liu S, Xue D, Liu Y, Zhang G (2018) Metabolic analysis of the antidepressive effects of yangxinshi tablet in a vascular depression model in mice. Biomed Chromatogr 32:e4114.\u00a0https:\/\/doi.org\/10.1002\/bmc.4114","DOI":"10.1002\/bmc.4114"},{"key":"1810_CR12","doi-asserted-by":"publisher","unstructured":"Fan L, Yang L, Li X, Teng T, Xiang Y, Liu X, Jiang Y, Zhu Y, Zhou X, Xie P (2021) Proteomic and metabolomic characterization of amygdala in chronic social defeat stress rats. Behav Brain Res 412:113407.\u00a0https:\/\/doi.org\/10.1016\/j.bbr.2021.113407","DOI":"10.1016\/j.bbr.2021.113407"},{"key":"1810_CR13","doi-asserted-by":"publisher","unstructured":"Farthing DE, Farthing CA, Xi L (2015) Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care. Experimental Biology Med 240:821\u2013831.\u00a0https:\/\/doi.org\/10.1177\/1535370215584931","DOI":"10.1177\/1535370215584931"},{"key":"1810_CR14","doi-asserted-by":"publisher","unstructured":"Filatova EV, Shadrina MI, Slominsky PA (2021) Major depression: one brain, one disease, one set of intertwined processes. Cells 10:1283.\u00a0https:\/\/doi.org\/10.3390\/cells10061283","DOI":"10.3390\/cells10061283"},{"key":"1810_CR15","doi-asserted-by":"publisher","unstructured":"Gan AK, Gibb BE (2025) Stress sensitivity in women with a history of recurrent versus first-episode major depression. Psychiatry Res, p 116382.\u00a0https:\/\/doi.org\/10.1016\/j.psychres.2025.116382","DOI":"10.1016\/j.psychres.2025.116382"},{"key":"1810_CR16","doi-asserted-by":"publisher","unstructured":"Guan W, Xu D-W, Ji C-H, Wang C-N, Liu Y, Tang W-Q, Gu J-H, Chen Y-M, Huang J, Liu J-F (2021) Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF. Pharmacol Res 174:105932.\u00a0https:\/\/doi.org\/10.1016\/j.phrs.2021.105932","DOI":"10.1016\/j.phrs.2021.105932"},{"key":"1810_CR17","doi-asserted-by":"publisher","unstructured":"Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O (2007) Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38:247\u2013252.\u00a0https:\/\/doi.org\/10.1016\/j.arcmed.2006.10.005","DOI":"10.1016\/j.arcmed.2006.10.005"},{"key":"1810_CR18","doi-asserted-by":"publisher","unstructured":"Hotopf M, Hardy R, Lewis G (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry 170:120.\u00a0https:\/\/doi.org\/10.1192\/bjp.170.2.120","DOI":"10.1192\/bjp.170.2.120"},{"key":"1810_CR19","doi-asserted-by":"publisher","unstructured":"Huang D, Wang L, Wu Y, Qin X, Du G, Zhou Y (2022) Metabolomics based on peripheral blood mononuclear cells to dissect the mechanisms of Chaigui granules for treating depression. ACS Omega 7:8466\u20138482.\u00a0https:\/\/doi.org\/10.1021\/acsomega.1c06046","DOI":"10.1021\/acsomega.1c06046"},{"key":"1810_CR20","doi-asserted-by":"publisher","unstructured":"Krenitsky TA, Spector T, Hall WW (1986) Xanthine oxidase from human liver: purification and characterization. Arch Biochem Biophys 247(1):108\u2013119.\u00a0https:\/\/doi.org\/10.1016\/0003-9861(86)90539-4","DOI":"10.1016\/0003-9861(86)90539-4"},{"key":"1810_CR21","doi-asserted-by":"publisher","unstructured":"Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R, Kendrick T, Kessler D, Mangin D, King M (2021) Maintenance or discontinuation of antidepressants in primary care. N Engl J Med 385(14):1257\u20131267.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2106356","DOI":"10.1056\/NEJMoa2106356"},{"key":"1810_CR22","doi-asserted-by":"publisher","unstructured":"Li Z, Ruan M, Chen J, Fang Y (2021) Major depressive disorder: advances in neuroscience research and translational applications. Neurosci Bull 37:863\u2013880.\u00a0https:\/\/doi.org\/10.1007\/s12264-021-00638-3","DOI":"10.1007\/s12264-021-00638-3"},{"key":"1810_CR23","doi-asserted-by":"publisher","unstructured":"Maes M, Almulla AF, You Z, Zhang Y (2025) Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat Reviews Neurol 21:473\u2013489.\u00a0https:\/\/doi.org\/10.1038\/s41582-025-01116-4","DOI":"10.1038\/s41582-025-01116-4"},{"issue":"17","key":"1810_CR24","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMra050730","volume":"353","author":"JJ Mann","year":"2005","unstructured":"Mann JJ (2005) The medical management of depression. N Engl J Med 353(17):1819\u20131834","journal-title":"N Engl J Med"},{"key":"1810_CR25","doi-asserted-by":"publisher","unstructured":"Michel TM, Camara S, Tatschner T, Frangou S, Sheldrick AJ, Riederer P, Gr\u00fcnblatt E (2010) Increased Xanthine oxidase in the thalamus and putamen in depression. World J Biol Psychiatry 11:314\u2013320.\u00a0https:\/\/doi.org\/10.3109\/15622970802123695","DOI":"10.3109\/15622970802123695"},{"key":"1810_CR26","doi-asserted-by":"publisher","unstructured":"Mocking RJ, Naviaux JC, Li K, Wang L, Monk JM, Bright AT, Figueroa CA, Schene AH, Ruh\u00e9 HG, Assies J (2021) Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence. Translational Psychiatry 11:37.\u00a0https:\/\/doi.org\/10.1038\/s41398-020-01182-w","DOI":"10.1038\/s41398-020-01182-w"},{"key":"1810_CR27","doi-asserted-by":"publisher","unstructured":"Nigatu YT, B\u00fcltmann U, Reijneveld SA (2015) The prospective association between obesity and major depression in the general population: does single or recurrent episode matter? BMC Public Health 15:1\u20138. https:\/\/doi.org\/10.1186\/s12889-015-1682-9","DOI":"10.1186\/s12889-015-1682-9"},{"key":"1810_CR28","doi-asserted-by":"publisher","unstructured":"Pan S, Ma Y, Yang R, Lu X, You Q, Ye T, Huang C (2022) Indole-3-carbinol selectively prevents chronic stress-induced depression-but not anxiety-like behaviors via suppressing pro-inflammatory cytokine production and oxido-nitrosative stress in the brain. Front Pharmacol 13:829966.\u00a0https:\/\/doi.org\/10.3389\/fphar.2022.829966","DOI":"10.3389\/fphar.2022.829966"},{"key":"1810_CR29","doi-asserted-by":"publisher","unstructured":"Predictable S, Laurencic G, Malone D (2006) Side effects of antidepressants: an overview. Clevel Clin J Med 73:351.\u00a0https:\/\/doi.org\/10.3949\/ccjm.73.4.351","DOI":"10.3949\/ccjm.73.4.351"},{"key":"1810_CR30","doi-asserted-by":"publisher","unstructured":"Pu J, Liu Y, Wu H, Liu C, Chen Y, Tang W, Yu Y, Gui S, Zhong X, Wang D (2025) Characterizing metabolomic and proteomic changes in depression: a systematic analysis. Mol Psychiatry 30:3120\u20133128.\u00a0https:\/\/doi.org\/10.1038\/s41380-025-02919-z","DOI":"10.1038\/s41380-025-02919-z"},{"key":"1810_CR31","doi-asserted-by":"publisher","unstructured":"Qiu J, Liu R, Ma Y, Li Y, Chen Z, He H, Chen J, Tong L, Huang C, You Q (2020) Lipopolysaccharide-induced depression-like behaviors is ameliorated by sodium butyrate via inhibiting neuroinflammation and oxido-nitrosative stress. Pharmacology 105:550\u2013560.\u00a0https:\/\/doi.org\/10.1159\/000505132","DOI":"10.1159\/000505132"},{"key":"1810_CR32","doi-asserted-by":"publisher","unstructured":"Roca M, Armengol S, Garc\u00eda-Garc\u00eda M, Rodriguez-Bay\u00f3n A, Ballesta I, Serrano MJ, Comas A, Gili M (2011) Clinical differences between first and recurrent episodes in depressive patients. Compr Psychiatr 52(1):26\u201332.\u00a0https:\/\/doi.org\/10.1016\/j.comppsych.2010.04.011","DOI":"10.1016\/j.comppsych.2010.04.011"},{"key":"1810_CR33","doi-asserted-by":"publisher","unstructured":"Shahar O, Botvinnik A, Shwartz A, Lerer E, Golding P, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K (2024) Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Mol Psychiatry 29:2059\u20132073.\u00a0https:\/\/doi.org\/10.1038\/s41380-024-02477-w","DOI":"10.1038\/s41380-024-02477-w"},{"key":"1810_CR34","doi-asserted-by":"publisher","unstructured":"Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD (2000) Multiple recurrences of major depressive disorder. Am J Psychiatry 157:229\u2013233.\u00a0https:\/\/doi.org\/10.1176\/appi.ajp.157.2.229","DOI":"10.1176\/appi.ajp.157.2.229"},{"key":"1810_CR35","doi-asserted-by":"publisher","unstructured":"Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan TW-M, Fiehn O, Goodacre R, Griffin JL (2007) Proposed minimum reporting standards for chemical analysis: chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3:211\u2013221.\u00a0https:\/\/doi.org\/10.1007\/s11306-007-0082-2","DOI":"10.1007\/s11306-007-0082-2"},{"key":"1810_CR36","doi-asserted-by":"publisher","unstructured":"Sun F, Yan J, Pang J, Song M, Wang M, Huang T, Zhao Z, Consortium D (2024) Distinct effects of first-episode and recurrent major depressive disorder on brain changes related to suicidal ideation: evidence from the REST-meta-MDD project. J Affect Disord 351:472\u2013480.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2024.01.213","DOI":"10.1016\/j.jad.2024.01.213"},{"key":"1810_CR37","doi-asserted-by":"publisher","unstructured":"Torok D, Krause S, Gecse K, Gal Z, Eszlari N, Csikos M, Bagdy G, Gonda X, Juhasz G, Petschner P (2025) Interaction of early life stress and NAD+\/SIRT1 pathway genetic risk promotes depression.\u00a0Transl Psychiatry 15:509. https:\/\/doi.org\/10.1038\/s41398-025-03733-5","DOI":"10.1038\/s41398-025-03733-5"},{"key":"1810_CR38","doi-asserted-by":"publisher","unstructured":"van Loo HM, Aggen SH, Gardner CO, Kendler KS (2015) Multiple risk factors predict recurrence of major depressive disorder in women. J Affect Disord 180:52\u201361.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2015.03.045","DOI":"10.1016\/j.jad.2015.03.045"},{"key":"1810_CR41","doi-asserted-by":"publisher","unstructured":"Wang Y, Deng M, Deng B, Ye L, Fei X, Huang Z (2019) Study on the diagnosis of gout with Xanthine and hypoxanthine. J Clin Lab Anal 33(5):e22868.\u00a0https:\/\/doi.org\/10.1002\/jcla.22868","DOI":"10.1002\/jcla.22868"},{"key":"1810_CR40","doi-asserted-by":"publisher","unstructured":"Wang Y, Cai X, Ma Y, Yang Y, Pan C-W, Zhu X, Ke C (2024) Metabolomics on depression: a comparison of clinical and animal research. J Affect Disord 349:559\u2013568.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2024.01.053","DOI":"10.1016\/j.jad.2024.01.053"},{"key":"1810_CR39","doi-asserted-by":"publisher","unstructured":"Wang J, Xie J, He F, Wu W, Xu K, Ren Y, Chen J, Xie P (2025) Akkermansia muciniphila-derived SCFAs improve the depression-like behaviors of mice by inhibiting neuroinflammation. Pharmacol Res 220:107938. https:\/\/doi.org\/10.1016\/j.phrs.2025.107938","DOI":"10.1016\/j.phrs.2025.107938"},{"key":"1810_CR42","doi-asserted-by":"publisher","unstructured":"Wu L, Chen J, Yu Q, Lu C, Shu Y (2024) Hypoxanthine produces rapid antidepressant effects by suppressing inflammation in serum and hippocampus. ACS Chem Neurosci 15:3970\u20133980.\u00a0https:\/\/doi.org\/10.1021\/acschemneuro.4c00345","DOI":"10.1021\/acschemneuro.4c00345"},{"key":"1810_CR43","doi-asserted-by":"publisher","unstructured":"Yang Y, Guan W (2025) From orphan receptor to inflammation regulation: the role of GPR35 in the pathogenesis of depression. Biochem Pharmacol 242(Pt 3):117370.\u00a0https:\/\/doi.org\/10.1016\/j.bcp.2025.117370","DOI":"10.1016\/j.bcp.2025.117370"},{"key":"1810_CR44","doi-asserted-by":"publisher","unstructured":"Ye J, Bi X, Deng S, Wang X, Liu Z, Suo Q, Wu J, Chen H, Wang Y, Qian K (2024a) Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke. Theranostics 14(15):6071.\u00a0https:\/\/doi.org\/10.7150\/thno.100090","DOI":"10.7150\/thno.100090"},{"key":"1810_CR45","doi-asserted-by":"publisher","unstructured":"Ye M, Ji F, Huang C, Li F, Zhang C, Zhang Y, Wang R, Ma K, Lu X, Wang H (2024b) A novel probiotic formula, BLLL, ameliorates chronic stress-induced depression-like behaviors in mice by reducing neuroinflammation and increasing neurotrophic factors. Front Pharmacol 15:1398292.\u00a0https:\/\/doi.org\/10.3389\/fphar.2024.1398292","DOI":"10.3389\/fphar.2024.1398292"},{"issue":"1","key":"1810_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12991-024-00522-0","volume":"23","author":"Y Yun","year":"2024","unstructured":"Yun Y, Mun S, Lee S, Kang HG, Lee J (2024) Serum L-selectin levels as predictive markers for chronic major depressive disorder progression. Ann Gen Psychiatry 23(1):37. https:\/\/doi.org\/10.1186\/s12991-024-00522-0","journal-title":"Ann Gen Psychiatry"},{"key":"1810_CR47","doi-asserted-by":"publisher","unstructured":"Zhang J-R, Shen S-Y, Zhai M-Y, Shen Z-Q, Li W, Liang L-F, Yin S-Y, Han Q-Q, Li B, Zhang Y-Q (2024) Augmented microglial Endoplasmic reticulum-mitochondria contacts mediate depression-like behavior in mice induced by chronic social defeat stress. Nat Commun 15:5199.\u00a0https:\/\/doi.org\/10.1038\/s41467-024-49597-z","DOI":"10.1038\/s41467-024-49597-z"},{"key":"1810_CR48","doi-asserted-by":"publisher","unstructured":"Zhao F, Tie N, Kwok L-Y, Ma T, Wang J, Man D, Yuan X, Li H, Pang L, Shi H (2024) Baseline gut Microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management. Pharmacol Res 209:107445.\u00a0https:\/\/doi.org\/10.1016\/j.phrs.2024.107445","DOI":"10.1016\/j.phrs.2024.107445"},{"key":"1810_CR49","doi-asserted-by":"publisher","unstructured":"Zhao K, Zhang Y, Yang S, Xiang L, Wu S, Dong J, Li H, Yu H, Hu W (2025) Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Front Cell Neurosci 19:1538026.\u00a0https:\/\/doi.org\/10.3389\/fncel.2025.1538026","DOI":"10.3389\/fncel.2025.1538026"},{"key":"1810_CR50","doi-asserted-by":"publisher","unstructured":"Zheng P, Chen J-j, Huang T, Wang M-j, Wang Y, Dong M-x, Huang Y-j, Zhou L-k, Xie P (2013) A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res 12:5904\u20135911.\u00a0https:\/\/doi.org\/10.1021\/pr400939q","DOI":"10.1021\/pr400939q"},{"key":"1810_CR51","doi-asserted-by":"publisher","unstructured":"Zheng P, Chen J, Zhou C, Zeng L, Li K, Sun L, Liu M, Zhu D, Liang Z, Xie P (2016) Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR-and GC\u2013MS-based metabonomics. Translational Psychiatry 6:e955\u2013e955.\u00a0https:\/\/doi.org\/10.1038\/tp.2016.188","DOI":"10.1038\/tp.2016.188"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01810-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:43:45Z","timestamp":1771926225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01810-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01810-2","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Eulji University (EU24-57, October 04, 2024) and carried out following the latest version of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}